pirenzepine has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilhelmy, R | 1 |
| Pitschner, H | 1 |
| Neuzner, J | 1 |
| Dürsch, M | 1 |
| König, S | 1 |
1 trial available for pirenzepine and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
Patients with AV nodal reentrant tachycardias show a reduced vagal impact on heart rate compared to healthy subjects with further decrease of vagal tone after radiofrequency catheter modification.
Topics: Adrenergic beta-Antagonists; Adult; Atropine; Catheter Ablation; Female; Heart Rate; Humans; Male; M | 1996 |